Interstitial lung disease in gefitinib-treated Japanese patients with non-small cell lung cancer – a retrospective analysis: JMTO LC03-02

BACKGROUND: In Japan, high incidences of interstitial lung disease (ILD) and ILD-related deaths have been reported among gefitinib-treated patients with non-small cell lung cancer (NSCLC). We investigated the efficacy of gefitinib, the incidence of ILD and risk factors for ILD in these patients. FIN...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Nakagawa, Masatsugu, Nishimura, Tsutomu, Teramukai, Satoshi, Tada, Harue, Tanaka, Fumihiro, Yanagihara, Kazuhiro, Furuse, Kiyoyuki, Wada, Hiromi, Fukushima, Masanori
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2009
Teme:
Short Report
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2736173/
https://ncbi.nlm.nih.gov/pubmed/19656374
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-0500-2-157
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items